Cellworks Life Revenue and Competitors
Estimated Revenue & Valuation
- Cellworks Life's estimated annual revenue is currently $27.6M per year.
- Cellworks Life's estimated revenue per employee is $155,000
Employee Data
- Cellworks Life has 178 Employees.
- Cellworks Life grew their employee count by 6% last year.
Cellworks Life's People
Name | Title | Email/Phone |
---|---|---|
1 | Senior Biomodeling Research Scientist | Reveal Email/Phone |
Cellworks Life Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Cellworks Life?
Cellworks is a world leader in Precision Medicine. We help physicians and payers navigate to the most efficacious, cost-effective treatments for patients in a transparent and timely manner. Cellworks' key therapeutic areas are Oncology, Immunology, Dermatology and Infectious Diseases. Cellworks' unique bio-simulation platform is a unified representation of biological knowledge, curated from heterogeneous datasets, applied to finding cure. Since 2005, backed by Artiman Ventures and Sequoia Capital, Cellworks has the world's strongest trans-disciplinary team of molecular biologists, cellular pathway modelers, and internet software technologists working towards a common goal – attacking serious diseases to improve the lives of patients.
keywords:N/AN/A
Total Funding
178
Number of Employees
$27.6M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $23.4M | 178 | 11% | $319.7M |
#2 | $37.2M | 192 | -7% | $92.1M |
#3 | $179.9M | 197 | -60% | $532.5M |
#4 | $31.5M | 203 | 1% | N/A |
#5 | $199.8M | 206 | 28% | $333.1M |